The Meninges Enhance Leukaemia Survival in Cerebral Spinal Fluid
Overview
Affiliations
Central nervous system (CNS) relapse is a common cause of treatment failure in patients with acute lymphoblastic leukaemia (ALL) despite current CNS-directed therapies that are also associated with significant short- and long-term toxicities. Herein, we showed that leukaemia cells exhibit decreased proliferation, elevated reactive oxygen species (ROS) and increased cell death in cerebral spinal fluid (CSF) both in vitro and in vivo. However, interactions between leukaemia and meningeal cells mitigated these adverse effects. This work expands our understanding of the pathophysiology of CNS leukaemia and suggests novel therapeutic approaches for more effectively targeting leukaemia cells in the CNS.
Ortiz-Sanchez P, Gonzalez-Soto S, Villamizar L, Valencia J, Jimenez E, Sacedon R Cell Oncol (Dordr). 2025; .
PMID: 39937211 DOI: 10.1007/s13402-025-01043-y.
CXCR4 antagonists disrupt leukaemia-meningeal cell adhesion and attenuate chemoresistance.
Jonart L, Ostergaard J, Brooks A, Fitzpatrick G, Chen L, Gordon P Br J Haematol. 2022; 201(3):459-469.
PMID: 36535585 PMC: 10121760. DOI: 10.1111/bjh.18607.
Metabolic Reprogramming and Cell Adhesion in Acute Leukemia Adaptation to the CNS Niche.
Sharma N, Keewan E, Matlawska-Wasowska K Front Cell Dev Biol. 2021; 9:767510.
PMID: 34957100 PMC: 8703109. DOI: 10.3389/fcell.2021.767510.
Ebadi M, Jonart L, Ostergaard J, Gordon P Sci Rep. 2021; 11(1):24374.
PMID: 34934147 PMC: 8692434. DOI: 10.1038/s41598-021-03929-x.
When the bond breaks - targeting adhesion of leukemia cells to the meninges.
Lenk L, Vogiatzi F, Schewe D Haematologica. 2020; 105(8):1991-1993.
PMID: 32739886 PMC: 7395289. DOI: 10.3324/haematol.2020.253609.